Off-Label Use of Biologic Agents in the Treatment of Dermatosis, Part 1: Infliximab and Adalimumab

Statistics

Review article

Uso de Fármacos Biológicos en Dermatosis Fuera de la Indicación Aprobada. Primera parte: Infliximab y Adalimumab

B. Díaz-Ley

Corresponding author

blancadiazley@hotmail.com

Correspondence: Servicio de Dermatología, Hospital Universitario de La Princesa, Diego de León, 62, 28006 Madrid, Spain.

, G. Guhl, J. Fernández-Herrera

Servicio de Dermatología, Hospital Universitario de La Princesa, Madrid, Spain

Read

7895

Times
was read the article

3277

Total PDF

4618

Total HTML

Share statistics

Article information

ISSN: 15782190
Original language: English

DOI:10.1016/S1578-2190(07)70539-5

The statistics are updated each day

Year/Month	Html	Pdf	Total

2024 November	71	47	118
2024 October	84	55	139
2024 September	63	44	107
2024 August	104	78	182
2024 July	65	49	114
2024 June	64	51	115
2024 May	67	34	101
2024 April	52	43	95
2024 March	65	51	116
2024 February	49	42	91
2024 January	48	40	88
2023 December	49	23	72
2023 November	49	35	84
2023 October	44	44	88
2023 September	61	27	88
2023 August	45	38	83
2023 July	35	70	105
2023 June	44	69	113
2023 May	43	22	65
2023 April	29	20	49
2023 March	46	39	85
2023 February	28	30	58
2023 January	37	23	60
2022 December	35	41	76
2022 November	26	30	56
2022 October	32	22	54
2022 September	29	43	72
2022 August	33	51	84
2022 July	23	36	59
2022 June	18	36	54
2022 May	44	48	92
2022 April	49	48	97
2022 March	38	52	90
2022 February	32	28	60
2022 January	33	39	72
2021 December	20	40	60
2021 November	43	49	92
2021 October	43	49	92
2021 September	30	48	78
2021 August	48	32	80
2021 July	46	28	74
2021 June	36	28	64
2021 May	22	25	47
2021 April	51	45	96
2021 March	66	25	91
2021 February	52	38	90
2021 January	41	30	71
2020 December	23	21	44
2020 November	34	19	53
2020 October	17	13	30
2020 September	39	19	58
2020 August	45	21	66
2020 July	26	19	45
2020 June	43	21	64
2020 May	25	20	45
2020 April	28	18	46
2020 March	42	29	71
2020 February	1	3	4
2020 January	0	4	4
2019 December	0	12	12
2019 November	0	9	9
2019 October	0	3	3
2019 September	0	7	7
2019 August	0	3	3
2019 July	0	18	18
2019 June	0	15	15
2019 May	0	41	41
2019 April	0	4	4
2019 March	0	5	5
2019 February	0	3	3
2019 January	0	4	4
2018 December	0	1	1
2018 September	0	5	5
2018 August	0	17	17
2018 July	0	6	6
2018 June	0	16	16
2018 May	0	13	13
2018 April	0	13	13
2018 March	2	6	8
2018 February	25	9	34
2018 January	21	8	29
2017 December	24	13	37
2017 November	24	8	32
2017 October	22	11	33
2017 September	23	13	36
2017 August	27	12	39
2017 July	26	7	33
2017 June	36	42	78
2017 May	31	17	48
2017 April	27	14	41
2017 March	21	13	34
2017 February	18	10	28
2017 January	23	13	36
2016 December	48	12	60
2016 November	45	12	57
2016 October	64	14	78
2016 September	72	20	92
2016 August	71	16	87
2016 July	47	10	57
2016 June	12	13	25
2016 May	6	14	20
2016 April	5	14	19
2016 March	3	8	11
2016 February	7	6	13
2016 January	5	3	8
2015 December	12	3	15
2015 November	10	4	14
2015 October	7	2	9
2015 September	10	10	20
2015 August	8	2	10
2015 July	52	1	53
2015 June	43	7	50
2015 May	94	19	113
2015 April	71	11	82
2015 March	50	11	61
2015 February	63	9	72
2015 January	58	25	83
2014 December	55	6	61
2014 November	31	9	40
2014 October	37	17	54
2014 September	42	14	56
2014 August	42	20	62
2014 July	48	20	68
2014 June	45	15	60
2014 May	64	15	79
2014 April	40	8	48
2014 March	44	26	70
2014 February	38	19	57
2014 January	38	25	63
2013 December	41	23	64
2013 November	29	18	47
2013 October	36	24	60
2013 September	35	36	71
2013 August	47	31	78
2013 July	46	63	109
2013 June	36	39	75
2013 May	34	32	66
2013 April	32	36	68
2013 March	52	28	80
2013 February	24	15	39
2013 January	14	9	23

Show all

Indexed in:

Follow us:

Statistics

Indexed in:

Follow us:

Statistics

Subscribe to our newsletter